ESC 365 - Angiotensin receptor and neprilysin inhibition for the treatment of hypertension

ESC Professional Premium Access

Angiotensin receptor and neprilysin inhibition for the treatment of hypertension

Session: Heart failure due to hypertension: innovative drug and device-based therapies

Topic: Chronic Heart Failure

Speaker: Professor J. Wang (Shanghai, CN)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor Jiguang Wang

Rui Jin Hospital- Shanghai Jiaotong University School of Medicine, Shanghai (China)

5 presentations

0 follower

3 more presentations in this session

The global contribution of hypertension to heart failure

Speaker: Professor M. Muiesan (Brescia, IT)

Blood pressure targets for patients with hypertension and heart failure

Speaker: Doctor L. Shen (Glasgow, CN)

Heart failure and hypertension management today and tomorrow

Speaker: Professor F. Ruschitzka (Zurich, CH)

Access the full session

Heart failure due to hypertension: innovative drug and device-based therapies

Speakers: Professor J. Wang, Professor M. Muiesan, Doctor L. Shen, Professor F. Ruschitzka

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources